Clinical Trial Update: A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register

View source ↗

Summary

A post-marketing safety study of abatacept in Sweden using the SRQ register has completed, evaluating safety in rheumatoid arthritis and psoriatic arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis, Psoriatic Arthritis | Status: COMPLETED